Compare
Polyrizon Ltd. vs Femasys Inc vs PolyPid Ltd. vs INVO Fertility, Inc.
| Latest fiscal year | Polyrizon Ltd. PLRZ | Femasys Inc FEMY | PolyPid Ltd. PYPD | INVO Fertility, Inc. IVF |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $2.29M | n/a | $6.84M |
| Revenue growth (YoY) | n/a | +40.8% | n/a | +4.7% |
| Gross margin | n/a | 62.0% (computed) | n/a | n/a |
| Operating margin | n/a | -767.0% | n/a | -105.8% |
| Net margin | n/a | -812.3% | n/a | -340.9% |
| Net income | -$3.33M | -$18.63M | -$34.17M | -$23.32M |
| EPS (Diluted) | $4.90 | -$0.47 | $2.09 | -$214.64 |
| Operating cash flow | -$4.53M | -$18.69M | -$27.88M | -$7.01M |
| Free cash flow | -$4.54M | -$19.22M | -$28.09M | -$7.06M |
| Cash & equivalents | $1.31M | $9.27M | $6.40M | n/a |
| Total assets | $21.44M | $20.72M | $22.31M | $20.22M |
| Total liabilities | n/a | $14.85M | n/a | $13.00M |
| Shareholders' equity | $20.99M | $5.87M | $10.97M | $7.22M |
| Return on year-end equity | -15.9% | -317.4% | -311.4% | -322.8% |
| Shares outstanding | 1.61M | 59.60M | 18.20M | 477.4K |
Revenue, most recent five fiscal years
| Fiscal year | Polyrizon Ltd. | Femasys Inc | PolyPid Ltd. | INVO Fertility, Inc. |
|---|---|---|---|---|
| Latest | n/a | $2.29M Ended 2025-12-31 | n/a | $6.84M Ended 2025-12-31 |
| 1 year earlier | n/a | $1.63M Ended 2024-12-31 | n/a | $6.53M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.07M Ended 2023-12-31 | n/a | $3.02M Ended 2023-12-31 |
| 3 years earlier | n/a | $1.21M Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $1.18M Ended 2021-12-31 | n/a | n/a |